![Pablo Jimenez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pablo Jimenez
Technik-/Wissenschafts-/F&E-Leiter bei Ziarco Group Ltd.
Profil
Pablo Jimenez is currently the Chief Medical Officer at Ziarco Group Ltd.
He previously held the same position at Celsus Therapeutics Plc from 2013 to 2015.
Prior to that, he was the Chief Medical Officer at Ziarco Pharma Ltd.
Dr. Jimenez earned a doctorate degree from Universidad Central Del Ecuador.
Aktive Positionen von Pablo Jimenez
Unternehmen | Position | Beginn |
---|---|---|
Ziarco Group Ltd.
![]() Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 20.07.2015 |
Ehemalige bekannte Positionen von Pablo Jimenez
Unternehmen | Position | Ende |
---|---|---|
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2015 |
Ziarco Pharma Ltd.
![]() Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Pablo Jimenez
Universidad Central Del Ecuador | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Ziarco Pharma Ltd.
![]() Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
Ziarco Group Ltd.
![]() Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Health Technology |